Abstract
Background Seroprevalence data and clinical studies in children suggest that the burden of pneumocystis pneumonia (PCP) in Africa may be underestimated. We performed a systematic review to determine the prevalence and attributable mortality of PCP amongst HIV-infected adults in sub-Saharan Africa.
Highlights
Dermatophytosis (Cutaneous Mycoses) have been reported worldwide as the most common cutaneous infectious diseases among humans in clinical practice
Apart from the above mentioned risk factors each patient in the 1st group with recurrent fungal infection had a history of treatment failure, attributing to steroid abuse, inadequate dosage of anti-fungal, lack of counselling and loss of follow up
From our study we concluded that patients with recurrent fungal infections act as the source of infection
Summary
Dermatophytosis (Cutaneous Mycoses) have been reported worldwide as the most common cutaneous infectious diseases among humans in clinical practice. In-spite of therapeutic advances in the last decades, the prevalence of cutaneous mycoses is still increasing. The skin constitutes the main site of recognizable fungal infections in humans. We aim at evaluating the possible contributing factors in the rise of prevalence of the disease. Seroprevalence data and clinical studies in children suggest that the burden of pneumocystis pneumonia (PCP) in Africa may be underestimated. We performed a systematic review to determine the prevalence and attributable mortality of PCP amongst HIV-infected adults in sub-Saharan Africa. Mucormycosis is an uncommon life-threatening fungal infection. The major risk factors of this infection include uncontrolled diabetes mellitus, prolonged steroid therapy, persistent neutropenia, haematological malignancies, autoimmune disorders, trauma, burn, and surgical wounds
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
